​

Funding Round

Series A - Torigen Pharmaceuticals

Series A - Torigen Pharmaceuticals

Investment Firm

Overview

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

Announced Date

Nov 16, 2022

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Connecticut Innovations

Connecticut Innovations

Connecticut Innovations is a debt and early_stage_venture and grant and late_stage_venture and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorUniversity of Notre Dame
Participant InvestorIronwood Capital
Participant InvestorGaingels
Participant InvestorAdvantage Capital
Participant InvestorConnecticut Innovations

Round Details and Background

Torigen Pharmaceuticals raised $13000000 on 2022-11-16 in Series A

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 05, 2018
Pre Seed Round - Torigen Pharmaceuticals
1-undefined
Feb 04, 2019
Series A - Torigen Pharmaceuticals
5-3.1M
Sep 01, 2018
Grant - Torigen Pharmaceuticals
-10.0K
Nov 16, 2022
Series A - Torigen Pharmaceuticals
11-13.0M

Recent Activity

There is no recent news or activity for this profile.